Sign Up to like & get
recommendations!
0
Published in 2021 at "Journal of Psychopharmacology"
DOI: 10.1177/0269881120981377
Abstract: Background: Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that prevents metabolic side effects of the antipsychotic drugs (APDs) olanzapine and clozapine through unknown mechanisms. Aim: This study aimed to investigate the effect of chronic…
read more here.
Keywords:
neural peripheral;
clozapine;
liraglutide treatment;
treatment ... See more keywords